Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population.

< BACK TO ARCHIVE


2022 Dec


Eur Rev Med Pharmacol Sci


http://www.ncbi.nlm.nih.gov/pubmed/36591876?dopt=Abstract


26


3 Suppl

Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population.

Authors

Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population.
Damiani G, Finelli R, Kridin K, Pacifico A, Bragazzi NL, Malagoli P, Fabbrocini G, Bonifazi E, Mazzotta F, Lovati C, Savoia P, Gironi LC, Morello M, Davidson T, Watad A, Goker F, Mortellaro C, Del Fabbro M
Eur Rev Med Pharmacol Sci. 2022 Dec; 26(3 Suppl):87-93.
PMID: 36591876.

Abstract

COVID-19 toes represent the main dermatological COVID-19 cutaneous manifestation in pediatric patients. Its diagnosis exposes the whole family to social stigma and this aspect was not previously evaluated.
Read This Paper